Waltham, MA According to Callahan Construction Managers, site work has been completed and structural steel installation is underway at 300 3rd Ave., which will be a 140,000 s/f life sciences building with four stories of flexible and customizable office and laboratory space. Callahan is the construction manager for the project, which is being developed by Lincoln Property Company and was designed by architect DiMella Shaffer.
300 3rd Avenue will feature an expansive glass curtain wall that will wrap the façade, which faces the Rte. 128 corridor. Each floor will span 35,000 ft. and will have bright light and expansive views from each of the workspaces. The building’s poured concrete foundation and steel frame concrete deck will be juxtaposed by a glass entrance accented by a natural wood ceiling, along with custom lighting. Finally, the building will include five levels of parking, two above grade and three below, as well as a mechanical penthouse and roof deck.
“This innovative and complex project is a significant addition to our company’s growing life sciences portfolio, as Boston’s life science market continues to lead the industry,” said Patrick Callahan, president of Callahan Construction Managers. “We look forward to delivering 300 3rd Ave. and our continued collaboration with our project partners.”
The city has emerged as one of Greater Boston’s most dynamic life sciences clusters. 300 3rd Ave. is located only 10 miles from Cambridge and Boston and is conveniently located off exit 27A on Rte. 128/I-95. Corporate neighbors include ThermoFisher, Sanofi, AstraZeneca, Shire, Deciphera, GSK, Alkermes, Immugen, PerkinElmer, Visterra and Exosome Dx.